US2009026123A1PendingUtilityA1

System for the production of autologus platelet gel useful for the delivery of medicinal and genetic agents

Individually held — no corporate assignee on recordPriority: Apr 30, 1996Filed: Aug 18, 2008Published: Jan 29, 2009
Est. expiryApr 30, 2016(expired)· nominal 20-yr term from priority
A61L 24/106
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A system for the production of a blood component composition is provided. The system includes a centrifuge having a blood reservoir for receiving and separating a blood sample into multiple components; a dispenser disposed outside of the centrifuge having a first collection chamber containing an activation agent and a second collection chamber containing one or more medicinal agents; means for removing a first portion at least one separated blood component from the centrifuge to the first container and a second portion to the second collection chamber, wherein the first collection chamber activates the first portion and stores the resulting clot and thrombin; a filter for separating the thrombin from the clot; and a nozzle for entraining and mixing the thrombin with the second portion containing the one or more medicinal components.

Claims

exact text as granted — not AI-modified
1 . A system of the production of a blood component composition, comprising:
 a centrifuge including a blood reservoir for receiving and separating an anticoagulated blood sample having multiple inactive blood components;   a dispenser being disposed outside of the centrifuge and the blood reservoir and having first collection chamber containing an activation agent and a second collection chamber containing one or more medicinal materials;   means for removing at least one of the inactive blood components upon separation from the centrifuge and delivering a first portion of the inactive blood component to the first collection chamber and a second portion of the inactive blood component to the second collection chamber, the first collection chamber activating the first portion of the inactive blood component and storing a resulting activated blood component comprising a clot and thrombin, the second collection chamber combining the second portion of the inactive blood component with the one or more medicinal materials;   a filter for separating the thrombin from the clot; and   a nozzle for entraining and mixing the thrombin with the second portion of the inactive blood component comprising the one or more medicinal materials thereby forming the blood component composition.   
   
   
       2 - 32 . (canceled)

Join the waitlist — get patent alerts

Track US2009026123A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.